NYSE:CVS
CVS HEALTH Corp
CVS HEALTH Corp's revenue grew 7.8% in fiscal 2025 to $402.1B while operating margin fell to 1.2%, its lowest in 10 years. Free cash flow was $7.8B, 1.9% of revenue, and the diluted share count rose 0.7%.Summary generated from CVS HEALTH Corp's SEC filings. Latest annual report filed Feb 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$402.1B
Revenue growth+7.8%
Revenue, 5-yr CAGR+8.4%
Gross margin45.0%
Operating margin1.2%
Net margin0.4%
ROIC2.8%
Return on equity2.3%
Debt / equity0.86
Free cash flow$7.8B
FCF margin1.9%
Share count change+0.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 292.1 | 322.5 | 357.8 | 372.8 | 402.1 |
| Operating income | 13.3 | 8.0 | 13.7 | 8.5 | 4.7 |
| Net income | 8.0 | 4.3 | 8.3 | 4.6 | 1.8 |
| Free cash flow | 15.7 | 13.4 | 10.4 | 6.3 | 7.8 |
Recent filings
- 8-KDirector or officer change
Aug 17, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 4Insider transaction report
Jun 29, 2026 - 4Insider transaction report
Jun 1, 2026 - 8-KDirector or officer change
May 18, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 6, 2026